Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.9M Buy
48,100
+8,100
+20% +$1.96M ﹤0.01% 1454
2026
Q2
$7.73M Buy
40,000
+29,700
+288% +$5.18M ﹤0.01% 1743
2026
Q1
$1.76M Sell
10,300
-55,900
-84% -$10.9M ﹤0.01% 2702
2025
Q4
$14.9M Buy
66,200
+49,900
+306% +$10.9M 0.01% 982
2025
Q3
$3.1M Sell
16,300
-81,100
-83% -$14.7M ﹤0.01% 1940
2025
Q2
$15.3M Buy
97,400
+84,100
+632% +$12.7M 0.01% 811
2025
Q1
$2.34M Buy
13,300
+1,700
+15% +$330K ﹤0.01% 1697
2024
Q4
$2.28M Sell
11,600
-10,600
-48% -$2.24M ﹤0.01% 1766
2024
Q3
$5.26M Buy
+22,200
New +$5.24M ﹤0.01% 1106

Other funds holding IQV

IMC Chicago's IQV Position: Q3 2026 in Review

IMC Chicago reduced its IQVIA (IQV) stake by 87% in Q3 2026, selling an estimated $9.5M and leaving 5,966 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3364.

IMC Chicago first reported a position in IQV in Q4 2025 and has held it in 3 quarters since. The position peaked at $12.7M in Q4 2025. 1,221 funds tracked by Wall St. Rank hold IQV as of Q3 2026.

  • IMC Chicago held 5,966 shares of IQVIA worth $1.6M as of Q3 2026.
  • IMC Chicago sold 39,450 IQVIA shares in Q3 2026, an estimated $9.5M.
  • IQVIA made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #3364 holding.
  • IMC Chicago first reported a position in IQVIA in Q4 2025 and has held it in 3 quarters since.
  • IMC Chicago's IQVIA position peaked at $12.7M in Q4 2025.
  • 1,221 funds tracked by Wall St. Rank held IQVIA as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.